Dermatitis Drugs Market Size, Global Industry Revenue by Segments, Key Players & Regions Forecast 2026
Sep 7, 2019
Dermatitis Drugs Market Size, Share and Global Trend by Drug Class (Calcineurin Inhibitors, PDE4 Inhibitors, Corticosteroids, Biologics & Others), By Disease Indication (Atopic Dermatitis, ontact Dermatitis & Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy & Online Pharmacy), and Geography Forecast to 2026
Pune, India - September 7, 2019 /MarketersMedia/ —
The Global Dermatitis Drugs Market will expand considerably in the coming years driven by the advancements across numerous drug classes. According to a report published by Fortune Business Insights, titled “Dermatitis Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 6,097.4 Mn in 2018. Fortune Business Insights predicts that the market will rise impressively at a CAGR of 10.2% and reach US$ 13,630.8 Mn by the end of 2026.
Browse Complete Report: https://www.fortunebusinessinsights.com/industry-reports/dermatitis-drugs-market-100658
Major Leading Players Mentioned:
• Valeant Pharmaceuticals
• Astellas Pharma US
• Pfizer
• Mylan
• Bayer
• Allergan
• LEO Pharma
• Regeneron Pharmaceuticals, Inc.
• Anacor Pharmaceuticals
The severity of dermatitis has led to an increasing need for efficient drugs. This, in turn, has led to a growing emphasis on the research and development of newer drugs that can be used in compliance with the regulations, enforced by related authorities. Increasing usage approvals will open up numerous windows for the growth of the global market. The report provides an in-depth analysis of various companies that have made significant contributions to the growth of the global dermatitis drugs market.
Topical Treatment for Atopic Dermatitis gets FDA Nod, Subsequently Aiding the Market’s Expansion
The global dermatitis drugs market will derive significant growth from increasing usage approvals. In 2017, the Food and Drug Administration passed approval for a new topical treatment for atopic dermatitis. The topical treatment ‘Eucrisa’ was aimed at the treatment of children and adults with mild to moderate atopic dermatitis. The use of Eucrisa to minimize the effects of dermatitis has fueled the demand for the products, across the world. The ability of Eucrisa to act on a body enzyme ‘PDE4’ has created several benefits of the product and this, in turn, will lead to an increase in adoption. After successful clinical trials, Eucrisa was seen to reduce skin rashes, itching, and lichenification. The applications of Eucrisa in the healthcare industry have had a positive impact on the Global Dermatitis Drugs Market and will favor the growth of the market in the coming years. Fortune Business Insights has predicted that growing usage approvals will bode well for the market in the near future.
Get Exclusive Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatitis-drugs-market-100658
Increasing Mergers and Acquisitions Will Enable Growth
The global atopic dermatitis market will witness growth opportunities due to contributions from leading companies and their exceptional business strategies. Recent trends in dermatitis treatment include company mergers and acquisitions, aimed at the betterment of prevailing drugs and creating new drugs. The growing mergers and acquisitions have boded well for the market and Fortune Business Insights has predicted that these activities will induce significant growth in the global dermatitis market in the coming years.
In 2016, Pfizer announced that it plans to acquire Anacor Pharmaceuticals for an estimated US$ 5.2 Bn. The company has splashed a huge amount for the take-over of Anacor and this is a strong indication of future growth. The report includes mergers and acquisition similar to the Pfizer-Anacor deal and gauges the impact of such M&As on the global dermatitis drugs market.
Major Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of major dermatitis types by key countries, 2018
4.2. Recent industry developments such as mergers & acquisitions
4.3. Pipeline analysis
4.4. Patent landscape
4.5. Reimbursement scenario by key countries
4.6. Regulatory scenario for key countries
TOC Continued…!
Get Discount: https://www.fortunebusinessinsights.com/enquiry/check-discount/dermatitis-drugs-market-100658
View More Related Reports:
Global Blood Glucose Meters Market Size, Share, Key Players Overview and Geographical Outlook 2026
Contact Info:
Name: Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt Ltd
Address: Fortune Business Insights Pvt. Ltd., 308, Supreme Headquarters,, Survey No. 36, Baner,, Pune-Bangalore Highway,, Pune - 411045, Maharashtra, India., , Phone:, US :+1 424 253 0390, UK : +44 2071 939123, APAC : +91 744 740 1245, Email: [email protected]
Phone: +14242530390
Website: https://www.fortunebusinessinsights.com/industry-reports/dermatitis-drugs-market-100658
Source: MarketersMedia
Release ID: 88916116
More News
Melbourne butcher robbed in overnight heist
A family butcher in Ivanhoe, in Melbourne's north-east, was ransacked in an overnight heist, with an estimated $8000 worth of meat stolen.
NAB announces it will cut thousands of jobs
The National Australia Bank has announced it will axe up to 2500 jobs over this financial year.
How to solve the hardest maths question in the 2026 HSC
Students at North Sydney Girls High said the final mathematics extension 2 was not without its hiccups but were able to solve it.
US sanctions 5 Chinese entities over ex-Google engineer’s AI trade secrets theft
The US State Department announced on Monday that it was imposing sweeping sanctions under the Protecting American Intellectual Property Act (PAIPA) on five Chinese entities suspected of stealing trade secrets from American companies. The targets include Shanghai Zhisuan Technology, founded by former Google software engineer Ding Linwei, venture capital firm MiraclePlus and three related entities. Ding was convicted of seven counts of trade secret theft in January. A federal judge subsequently...
Saudis postpone investment conference until 2027 amid fighting with Houthis
The Saudi government has postponed its annual investment conference — known colloquially as “Davos in the Desert” — to next year, after the Iran-backed Houthi rebels carried out multiple deadly attacks on Saudi Arabia earlier this month. Organizers at the Future Investment Initiative (FII) Institute postponed the 10th edition of the conference, which was set...
‘Humbled, not a hero’: Dad who put himself in danger to save Helen Haines speaks
Ricky Jefferies thought it was a car accident. Then he saw the knife.
Haines critical after emergency surgery following 'attack', as 'hero' speaks
The joint counter-terrorism unit has joined the investigation: PM.
US-China negotiators race to nail down concrete deals as Shenzhen Apec looms
The US and China are racing to secure concrete investment deals ahead of their leaders’ meeting in Shenzhen next month, even as both sides engage in a contest over leverage in extending their broad trade agreement. Multiple sources told the South China Morning Post that intense negotiations would continue in coming weeks, with Washington and Beijing still facing hurdles to finalising a complex package of institutional frameworks and economic agreements. The sources, who spoke on condition of...
'Sad reality': ACT parliament contracts armed guards as threats escalate
Armed guards picked to patrol territory's parliament for the first time.
Albanese says all Australians will be thinking of Helen Haines today
Indi MP Helen Haines is in a critical condition after she was allegedly struck by a car driven by a 43-year-old male driver outside her electorate office in Wangaratta, in north-east Victoria.
US orders DeepSeek removed from federal systems, citing national security risks
Citing national security concerns, the US government has ordered federal civilian agencies to remove DeepSeek products and any third-party services developed using the Chinese artificial intelligence model from their information systems. In a notice made public on Monday, the Department of Homeland Security (DHS) also barred agencies from acquiring DeepSeek products and services, including those developed by affiliated entities. The notice said that using the company’s products “may result in...
What we know so far about the attack on Helen Haines as MP in critical condition
Prime Minister Anthony Albanese has said that the attack was deliberate. Haines remains in critical condition.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.